Moderna looks at producing a Monkeypox vaccine

Coronavirus, Health, Infection, Moderna, Monkeypox, Revaccination, Texas, Transmission, USA, Vaccine, Zoonosis

Moderna is considering turning its mRNA vaccine platform towards finding a vaccine to defend against Monkeypox, according to a recent tweet by the company.

There are currently two approved vaccines in the U.S. for smallpox which should be effective against Monkeypox. One is made by Acambis (since bought by Sanofi), the other made by Bavarian Nordic.

Moderna’s preclinical trials on a Monkeypox vaccine will add to its work on a host of other products, including vaccines for Covid-19, the flu, the common cold and RSV.



Moderna’s Twitter bio:





** This post was originally published on May 24, 2022 **